BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
BALAXI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Balaxi Pharmaceuticals Limited has submitted a statement of deviation(s) or variation(s) under Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations to the NSE. This filing relates to the monitoring of funds raised through a prior public, rights, or preferential issue, comparing the projected use of proceeds with the actual deployment. The exact details of any deviations or variations have not been disclosed in this headline-level announcement and would be in the attached document. Such filings are typically done quarterly as part of ongoing SEBI compliance obligations.
This is a routine regulatory compliance filing and is unlikely to have a material impact on the stock price unless the detailed statement reveals significant unexplained deviations in the use of raised funds. Shareholders should review the attached document for any material variations before drawing conclusions.